Clinical Trials Browser

Observational × HER2+ Breast Cancer × Clear all

NCT06537674 2024-08-05

Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer

Not yet recruiting

HER2+ Breast Cancer

NCT05931042 2023-07-05

Neoadjuvant Therapy With Trastuzumab and Chemotherapy and the Resultant Pathologic Complete Response Observed in HER2 Positive Breast Cancer;a Systematic Review

HER2+ Breast Cancer